CRISPR Therapeutics AG (CRSP) Other Working Capital Changes (2017 - 2026)
CRISPR Therapeutics AG (CRSP) reported Other Working Capital Changes of -$427000.0 for Q1 2026, up 48.18% on a YoY basis from -$288163.8 in Q1 2025, and down 119.83% sequentially from $2.2 million in Q4 2025.
CRISPR Therapeutics AG (CRSP) Other Working Capital Changes (2017 - 2026) Analysis & Trends
CRISPR Therapeutics AG (CRSP) has 10 years of Other Working Capital Changes data on file, last reported at -$427000.0 in Q1 2026.
- For the quarter ending Q1 2026, Other Working Capital Changes rose 48.18% year-over-year to -$427000.0; the trailing twelve-month figure through Dec 2025 stood at -$397000.0 (up 79.63% YoY), and the FY2025 full-year result was -$397000.0, up 79.63% from the prior year.
- Other Working Capital Changes fell to -$427000.0 in Q1 2026, from $2.2 million in the prior quarter.
- In the past five years, Other Working Capital Changes ranged from a high of $5.5 million in Q4 2022 to a low of -$12.0 million in Q1 2023.
- A 5-year average of -$2.0 million and a median of -$817000.0 in 2023 frame the typical range for Other Working Capital Changes.
- Across the five-year window, Other Working Capital Changes plunged 6125.0% in 2022 and surged 2711.24% in 2023, its largest moves.
- Tracing CRSP's Other Working Capital Changes over 5 years: stood at -$249000.0 in 2022, then plunged by 384.34% to -$1.2 million in 2023, then jumped by 47.1% to -$638000.0 in 2024, then jumped by 437.46% to $2.2 million in 2025, then sank by 119.83% to -$427000.0 in 2026.
- Business Quant data shows CRSP's Other Working Capital Changes at -$427000.0 in Q1 2026, $2.2 million in Q4 2025, and -$834000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | CRISPR Therapeutics AG | 4.57 Bn | 2.12 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -427,000.00 |
| Mar 31, 2026 | -427,000.00 |
| Mar 31, 2026 | -427,000.00 |
| Dec 31, 2025 | 2.15 Mn |
| Dec 31, 2025 | 2.15 Mn |
| Dec 31, 2025 | 2.15 Mn |
| Sep 30, 2025 | -834,000.00 |
| Sep 30, 2025 | -834,000.00 |
| Sep 30, 2025 | -834,000.00 |
| Jun 30, 2025 | -892,000.00 |
| Jun 30, 2025 | -892,000.00 |
| Jun 30, 2025 | -892,000.00 |
| Mar 31, 2025 | -824,000.00 |
| Mar 31, 2025 | -824,000.00 |
| Mar 31, 2025 | -824,000.00 |
| Dec 31, 2024 | -638,000.00 |
| Dec 31, 2024 | -638,000.00 |
| Dec 31, 2024 | -638,000.00 |
| Sep 30, 2024 | -536,000.00 |
| Sep 30, 2024 | -536,000.00 |